4 Results for "

FF2039

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "FF2039" in MCE Product Catalog:

Cat. No.: HY-172159
Target:  

PROTACs HDAC Apoptosis

Research Areas:  

Neurological Disease Cancer

FF2039 is a pan-HDAC PROTAC degrader that binds to DCAF11, acting on HDAC6, HDAC1, HDAC2 and HDAC4. FF2039 recruits the DCAF11 E3 ligase and mediates the polyubiquitination and degradation of HDACs via the ubiquitin-proteasome system. FF2039 induces cell cycle arrest, apoptosis, cytotoxicity and antiproliferative activity in cancer cells, and reduces the clonogenic capacity of cancer cells. FF2039 is applicable to research related to multiple myeloma, triple-negative breast cancer and glioblastoma .
loading...
    loading...
Cat. No.: HY-W957284
CAS No.: 2940939-13-7
Target:  

Ligands for E3 Ligase

Research Areas:  

Cancer

DCAF11 ligand 1 is the ligand for E3 ligase DCAF11 and can be used for PROTAC synthesis of FF2039 (HY-172159) .
loading...
    loading...
Cat. No.: HY-W881439
CAS No.: 2703752-86-5
Target:  

PROTAC Linkers

Research Areas:  

Cancer

1-(1,1-Dimethylethyl) tridecanedioate is a PROTAC Linker and can be used for PROTAC synthesis, such as FF2039 (HY-172159) .
loading...
    loading...
Cat. No.: HY-172185
Research Areas:  

Cancer

E3 Ligase Ligand-linker Conjugate 172 is the conjugate composed of an E3 ligase ligand and a linker, and can be used for synthesis of PROTAC degrader FF2039 (HY-172159) .
loading...
    loading...